These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31729202)

  • 1. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin-guided antibiotic therapy: an expert consensus.
    Bartoletti M; Antonelli M; Bruno Blasi FA; Casagranda I; Chieregato A; Fumagalli R; Girardis M; Pieralli F; Plebani M; Rossolini GM; Sartelli M; Viaggi B; Viale P; Viscoli C; Pea F
    Clin Chem Lab Med; 2018 Jul; 56(8):1223-1229. PubMed ID: 29874192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.
    Wilke MH; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Dec; 16(12):543-8. PubMed ID: 22112361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use.
    Schuetz P; Beishuizen A; Broyles M; Ferrer R; Gavazzi G; Gluck EH; González Del Castillo J; Jensen JU; Kanizsai PL; Kwa ALH; Krueger S; Luyt CE; Oppert M; Plebani M; Shlyapnikov SA; Toccafondi G; Townsend J; Welte T; Saeed K
    Clin Chem Lab Med; 2019 Aug; 57(9):1308-1318. PubMed ID: 30721141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to best use procalcitonin to diagnose infections and manage antibiotic treatment.
    Schuetz P
    Clin Chem Lab Med; 2023 Apr; 61(5):822-828. PubMed ID: 36317790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin: Between evidence and critical issues.
    Aloisio E; Dolci A; Panteghini M
    Clin Chim Acta; 2019 Sep; 496():7-12. PubMed ID: 31194966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
    Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.
    Fantoni M; Taddei E; Cauda R; Antonelli Incalzi R; Capone A; Cortese F; Sanguinetti M; Spandonaro F; Urbani A; Murri R
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2978-2985. PubMed ID: 31002168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin in special patient populations: Guidance for antimicrobial therapy.
    Smith SE; Muir J; Kalabalik-Hoganson J
    Am J Health Syst Pharm; 2020 May; 77(10):745-758. PubMed ID: 32340027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.